Showing results (31-40 of 622) with videos related to

Sort By:
Pageof 63
European Urology Oncology|November 25, 2022
Positive Prostate-specific Membrane Antigen Findings: How To Interpret ThemKelsey L Pomykala, Ken Herrmann, Elisabetta Lalumera, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 14, 2021
Hybrid total-body pet scanners-current status and future perspectivesVanessa Nadig, Ken Herrmann, Felix M Mottaghy, et al.
Gastrointestinal Cancer Research : GCR|March 5, 2009
The Value of PET Imaging in Patients with Localized Gastroesophageal CancerKatja Ott, Ken Herrmann, Bernd-Joachim Krause, et al.
Expert Review of Medical Devices|February 16, 2016
3D scintigraphic imaging and navigation in radioguided surgery: freehand SPECT technology and its clinical applicationsChristina Bluemel, Philipp Matthies, Ken Herrmann, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 19, 2011
Pancreatic and hepatobiliary cancersAndreas K Buck, Ken Herrmann, Florian Eckel, et al.
Clinical Nuclear Medicine|June 17, 2022
False Positive Ventilation/Perfusion SPECT/CT Mismatch Mimicking Pulmonary Embolism in a Patient With Bilateral Lung TransplantPatrick Sandach, Björn Kleibrink, Sandra Maier, et al.
Seminars in Nuclear Medicine|March 14, 2024
Radiotheranostics Global Market and Future DevelopmentsAkram Al-Ibraheem, Richard Zimmermann, Ahmed S Abdlkadir, et al.
The British Journal of Radiology|May 14, 2020
Nuclear medicine and molecular imaging advances in the 21st centurySofia C Vaz, Francisco Oliveira, Ken Herrmann, et al.
Nuclear Medicine and Biology|May 21, 2021
The salivary glands as a dose limiting organ of PSMA- targeted radionuclide therapy: A review of the lessons learnt so farNathalie Heynickx, Ken Herrmann, Koen Vermeulen, et al.
Methods (San Diego, Calif.)|July 2, 2017
PSMA ligands in prostate cancer - Probe optimization and theranostic applicationsSusanne Lütje, Roger Slavik, Wolfgang Fendler, et al.
Pageof 63